发明专利
JP2009173660A Peptide vaccine for lung cancer expressing ttk, urlc10 or koc1 polypeptides
有权
肺癌用于表达TTK，URLC10或KOC1多肽的肺癌疫苗
- 专利标题： Peptide vaccine for lung cancer expressing ttk, urlc10 or koc1 polypeptides
- 专利标题（中）： 肺癌用于表达TTK，URLC10或KOC1多肽的肺癌疫苗
-
申请号： JP2009058798申请日： 2009-03-12
-
公开(公告)号： JP2009173660A公开(公告)日： 2009-08-06
- 发明人: TAWARA HIDEAKI , TSUNODA TAKUYA , NAKAMURA YUSUKE , DAIGO YATARO , NAKAZURU SHUICHI
- 申请人： Oncotherapy Science Ltd , オンコセラピー・サイエンス株式会社
- 专利权人： Oncotherapy Science Ltd,オンコセラピー・サイエンス株式会社
- 当前专利权人： Oncotherapy Science Ltd,オンコセラピー・サイエンス株式会社
- 优先权： US65685705 2005-02-25
- 主分类号： C07K7/06
- IPC分类号： C07K7/06 ; A61K39/00 ; A61K48/00 ; A61P35/00 ; C07K7/08 ; C12N5/06 ; C12N15/09
摘要：
PROBLEM TO BE SOLVED: To provide immunogenic peptides which are specifically upward controlled with tumor cells of lung cancer tissues, are useful for killing the tumor cells, and are originated from TTK, URLC10 or KOC1. SOLUTION: There are provided: peptides comprising specific amino acid sequences; as well as peptides comprising the above amino acid sequences in which 1, 2, or several amino acids are substituted, deleted, or added, and having cytotoxic T cell inducibility. Medicines for treating or preventing tumors comprises these peptides. The peptides can also be used as vaccines. COPYRIGHT: (C)2009,JPO&INPIT
公开/授权文献
信息查询
